Cantor Fitzgerald Reiterates Overweight on ALX Oncology Holdings
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on ALX Oncology Holdings (NASDAQ:ALXO).
August 12, 2024 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on ALX Oncology Holdings (NASDAQ:ALXO).
The reiteration of an Overweight rating by a reputable analyst can boost investor confidence and potentially lead to a short-term increase in the stock price of ALX Oncology Holdings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100